Cargando…
Genetic variants in the plasminogen activator inhibitor‐1 gene are associated with an increased risk of radiation pneumonitis in lung cancer patients
Plasminogen activator inhibitor‐1 (PAI‐1) plays a crucial role in the process of lung injury, although its association with radiation pneumonitis (RP) is unclear. We hypothesized that genetic variants in PAI‐1 may influence the risk of RP. In this study, 169 lung cancer patients were genotyped for s...
Autores principales: | Liu, Bo, Tang, Yang, Yi, Minxiao, Liu, Qingxu, Xiong, Huihua, Hu, Guangyuan, Yuan, Xianglin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345627/ https://www.ncbi.nlm.nih.gov/pubmed/28211612 http://dx.doi.org/10.1002/cam4.1011 |
Ejemplares similares
-
Genetic variants of SP‐D confer susceptibility to radiation pneumonitis in lung cancer patients undergoing thoracic radiation therapy
por: Xu, Li, et al.
Publicado: (2019) -
Genetic variants in PI3K/AKT pathway are associated with severe radiation pneumonitis in lung cancer patients treated with radiation therapy
por: Tang, Yang, et al.
Publicado: (2015) -
Risk of immune‐related pneumonitis for PD1/PD‐L1 inhibitors: Systematic review and network meta‐analysis
por: Huang, Yafang, et al.
Publicado: (2019) -
Risk factors for pneumonitis in patients treated with anti‐programmed death‐1 therapy: A case‐control study
por: Cui, Pengfei, et al.
Publicado: (2018) -
Radiation‐associated sarcoma after breast cancer in a nationwide population: Increasing risk of angiosarcoma
por: Salminen, Samuli H., et al.
Publicado: (2018)